GSDMD-dependent IL-1 signaling in intestinal inflammation
肠道炎症中 GSDMD 依赖性 IL-1 信号传导
基本信息
- 批准号:10441357
- 负责人:
- 金额:$ 54.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-24 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAddressAttenuatedAutomobile DrivingBinding ProteinsBiochemicalBiochemistryBiological AssayBiopsyCASP1 geneCASP8 geneCDC37 geneCDC37 homolog proteinCell physiologyCellsChronicColitisColonComplementComplexCrohn&aposs diseaseDataDiseaseElectron MicroscopyEpithelial CellsEtiologyEventExtracellular SpaceFamily memberFinancial compensationGenetic PolymorphismHelper-Inducer T-LymphocyteIL1R1 geneImmuneIn VitroInflammasomeInflammationInflammatoryInflammatory Bowel DiseasesInterleukin-1Interleukin-1 betaIntestinal SecretionsIntestinesKnowledgeLengthLipid BindingLiteratureMapsMediatingModelingMolecularMolecular ChaperonesMusMutationMyeloid CellsNonlyticPathogenesisPathogenicityPathway interactionsPatientsPeptide Signal SequencesPersonsPolyubiquitinationPredispositionPreventive measureProcessProductionProteinsProteomicsRegulationRoleSecretory VesiclesSignal TransductionSodium Dextran SulfateSourceStimulusT-LymphocyteTCR ActivationTestingTissuesUbiquitinationUlcerative ColitisUnited StatesVesicleanakinrabasecell typecytokinedesigndextran sulfate sodium induced colitiseffective therapyextracellular vesiclesgut inflammationin vivoinsightintestinal epitheliummouse modelnovelnovel therapeutic interventionprogramspublic health relevancerapid growthreceptorrecruitresponsetargeted treatmenttherapeutic targetubiquitin-protein ligasevesicular release
项目摘要
Abstract:
About 1.3 million people suffer from IBD (chronic inflammation of the intestine) in the United States. The etiology
of IBD remains elusive and preventive measures or a cure are not available. Inflammasomes and derived
cytokines IL-1β are being intensely investigated as the signaling hub that is dys-regulated in inflammatory bowel
disease (IBD). IL-1β is synthesized as inactive pro-forms with no secretory signal sequence. Recent studies
have found that a lipid binding protein, Gasdermin D (GSDMD), is required for release of IL-1β in response to
caspase-1/11 inflammasome activation. This breakthrough led to a rapid growth of literature that focuses on the
pore forming and associated pyroptotic activity of GSDMD in myeloid cells. Interestingly, we discovered a novel
nonpyrototic role of GSDMD in guiding the release of IL-1β containing vesicles from intestinal epithelia cells and
T cells in response to Caspase 8 (Casp8) but not casp1 activation. Through unbiased proteomic analysis, we
identified a set of novel GSDMD-interacting proteins in intestinal epithelial cells (IECs), including NEDD4 (an E3
ligase) and the Hsp90 co-chaperone CDC37. Ablation of GSDMD or NEDD4 abolished LPS and ATP-induced
IL-1β production from IECs. Strikingly, LPS+ATP stimulation led to the polyubiquitination of pro-IL-1β, which was
secreted and processed into mature IL-1β along with a complex containing full-length GSDMD, Hsp90/CDC37,
NEDD4, Atg7, Casp8 but not Casp1. In vitro ubiquitination assay demonstrated that NEDD4, known to interact
with LC3 and promote cargo loading into secretory vesicles, catalyzed the polyubiquitination of pro-IL-1β. Indeed,
while GSDMD was associated with LC3+ vesicles; GSDMD-dependent release of extracellular vesicles (< 200
nm) were detected by electron microscopy, which contains the GSDMD/NEDD4/IL-1β complex. Moreover,
inactivating mutation in the Asp276 of GSDMD, which abolishes its pore-forming and pyroptotic activity, did not
impact the GSDMD-guided IL-1β secretion from IECs. In TH17 cells, a T helper cell subset highly relevant to
intestinal inflammation, this GSDMD-guided secretion of polyubiquitinated pro-IL-1β complex (GSDMD, Hsp90,
Casp8 and NEDD4) was also readily detected in response to ATP stimulation and TCR activation. Collectively,
the data revealed a novel nonpyroptotic role for GSDMD in IL-1β release from non-myeloid cells. The pathogenic
role of the GSDMD-guided IL-1β release was investigated in two mouse models of intestinal inflammation. Firstly,
while polyubiquitinated pro-IL-1β, mIL-1β and the GSDMD/NEDD4-secretary complex were induced in a
GSDMD-dependent manner in the intestinal explants in response to dextran sodium sulfate (DSS)-induce colitis,
GSDMD-deficiency attenuated the intestinal inflammation. Secondly, GSDMD or IL-1β deficiency in naïve T cells
reduced their ability to elicit intestinal inflammation. Based on these findings, we hypothesize that the GSDMD
mediates distinct pathways (guided secretion and pyroptosis) for IL-1β release in non-myeloid and myeloid cells,
which jointly contribute to the pathogenesis of intestinal inflammation in a coordinated manner. We will test this
hypothesis through the following aims: (1) Investigate the molecular mechanism for GSDMD-guided secretory
pathway for IL-1β release; (2) Investigate the cell-type and pathway-specific role of GSDMD-IL-1β axis in
intestinal inflammation, including GSDMD-mediated pyroptotic versus GSDMD-guided IL-1β secretion on the
intestinal inflammation.
抽象的:
在美国,大约有 130 万人患有 IBD(慢性肠道炎症)。
IBD 的发病率仍然难以捉摸,并且尚无炎症小体及其衍生的预防措施或治疗方法。
细胞因子 IL-1β 作为炎症性肠中失调的信号中枢正在受到深入研究
IL-1β 被合成为无活性的前体形式,没有分泌信号序列。
已经发现,脂质结合蛋白 Gasdermin D (GSDMD) 是释放 IL-1β 所必需的,以响应
caspase-1/11 炎症小体激活这一突破导致关注 caspase-1/11 炎症小体激活的文献迅速增长。
骨髓细胞中 GSDMD 的孔形成和相关的焦亡活性。
GSDMD 在引导肠上皮细胞释放含有 IL-1β 的囊泡中的非热解作用
T 细胞响应 Caspase 8 (Casp8),但不响应 casp1 激活。
在肠上皮细胞 (IEC) 中鉴定了一组新型 GSDMD 相互作用蛋白,包括 NEDD4(一种 E3
连接酶)和 Hsp90 共伴侣 CDC37 的消除 GSDMD 或 NEDD4 消除了 LPS 和 ATP 诱导的。
引人注目的是,LPS+ATP 刺激导致 IL-1β 前体的多泛素化。
分泌并加工成成熟的 IL-1β 以及含有全长 GSDMD、Hsp90/CDC37 的复合物,
NEDD4、Atg7、Casp8 但不包括 Casp1 体外泛素化测定表明 NEDD4 会相互作用。
与 LC3 结合并促进货物装载到分泌囊泡中,催化 pro-IL-1β 的多泛素化。
而 GSDMD 与 LC3+ 囊泡依赖性细胞外囊泡释放相关(< 200)
nm)通过电子显微镜检测,其中含有GSDMD/NEDD4/IL-1β复合物。
GSDMD 的 Asp276 失活突变消除了其成孔和焦亡活性,但并未
影响 GSDMD 引导的 IEC 分泌 IL-1β 在 TH17 细胞中,TH17 细胞与 T 辅助细胞亚群高度相关。
肠道炎症,这种 GSDMD 引导的多泛素化前 IL-1β 复合物(GSDMD、Hsp90、
Casp8 和 NEDD4) 也很容易检测到对 ATP 刺激和 TCR 激活的反应。
数据揭示了 GSDMD 在非骨髓细胞释放 IL-1β 中的新的非焦亡作用。
在两种肠道炎症小鼠模型中研究了 GSDMD 引导的 IL-1β 释放的作用。
而多泛素化的 pro-IL-1β、mIL-1β 和 GSDMD/NEDD4 分泌复合物在
肠外植体中 GSDMD 依赖性方式响应葡聚糖硫酸钠 (DSS) 诱导的结肠炎,
其次,幼稚 T 细胞中 GSDMD 或 IL-1β 缺乏会减轻肠道炎症。
降低了它们引发肠道炎症的能力。基于这些发现,我们发现 GSDMD 是有效的。
介导非髓细胞和髓细胞中 IL-1β 释放的不同途径(引导分泌和细胞焦亡),
它们以协调的方式共同促进肠道炎症的发病机制,我们将对此进行测试。
通过以下目标提出假设:(1)研究GSDMD引导分泌的分子机制
IL-1β 释放途径;(2) 研究 GSDMD-IL-1β 轴在细胞类型和途径中的特异性作用
肠道炎症,包括 GSDMD 介导的焦亡与 GSDMD 引导的 IL-1β 分泌
肠道炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theresa Torres Pizarro其他文献
Theresa Torres Pizarro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theresa Torres Pizarro', 18)}}的其他基金
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
GSDMD依赖性肠上皮细胞外囊泡在IBD中的致病作用
- 批准号:
10853519 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
GSDMD依赖性肠上皮细胞外囊泡在IBD中的致病作用
- 批准号:
10211603 - 财政年份:2021
- 资助金额:
$ 54.17万 - 项目类别:
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
GSDMD依赖性肠上皮细胞外囊泡在IBD中的致病作用
- 批准号:
10211603 - 财政年份:2021
- 资助金额:
$ 54.17万 - 项目类别:
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
GSDMD依赖性肠上皮细胞外囊泡在IBD中的致病作用
- 批准号:
10599251 - 财政年份:2021
- 资助金额:
$ 54.17万 - 项目类别:
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
GSDMD依赖性肠上皮细胞外囊泡在IBD中的致病作用
- 批准号:
10386894 - 财政年份:2021
- 资助金额:
$ 54.17万 - 项目类别:
GSDMD-dependent IL-1 signaling in intestinal inflammation
肠道炎症中 GSDMD 依赖性 IL-1 信号传导
- 批准号:
10654589 - 财政年份:2020
- 资助金额:
$ 54.17万 - 项目类别:
GSDMD-dependent IL-1 signaling in intestinal inflammation
肠道炎症中 GSDMD 依赖性 IL-1 信号传导
- 批准号:
10223160 - 财政年份:2020
- 资助金额:
$ 54.17万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Mitochondrial proton leak and neonatal brain injury
线粒体质子泄漏与新生儿脑损伤
- 批准号:
10724518 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
The role of the nigrothalamic pathway in opioid-driven behaviors
黑丘脑通路在阿片类药物驱动行为中的作用
- 批准号:
10730268 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Glutaredoxin, Glutathione Metabolism and Lung Cancer
谷氧还蛋白、谷胱甘肽代谢与肺癌
- 批准号:
10657945 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
通过调节肿瘤炎症提高胶质瘤免疫治疗效果
- 批准号:
10750788 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis
实验性坏死性小肠结肠炎中的α间抑制剂
- 批准号:
10822492 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别: